- Home
- CCEL vs APYX Comparison
CCEL vs APYX Comparison
Compare CCEL & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- APYX
- Stock Information
- Founded
- CCEL 1989
- APYX 1982
- Country
- CCEL United States
- APYX United States
- Employees
- CCEL N/A
- APYX N/A
- Industry
- CCEL Managed Health Care
- APYX Medical/Dental Instruments
- Sector
- CCEL Health Care
- APYX Health Care
- Exchange
- CCEL Nasdaq
- APYX Nasdaq
- Market Cap
- CCEL 50.0M
- APYX 42.3M
- IPO Year
- CCEL 1997
- APYX 1987
- Fundamental
- Price
- CCEL $7.80
- APYX $1.69
- Analyst Decision
- CCEL
- APYX Hold
- Analyst Count
- CCEL 0
- APYX 2
- Target Price
- CCEL N/A
- APYX N/A
- AVG Volume (30 Days)
- CCEL 13.9K
- APYX 68.5K
- Earning Date
- CCEL 12-24-2024
- APYX 11-08-2024
- Dividend Yield
- CCEL 3.14%
- APYX N/A
- EPS Growth
- CCEL N/A
- APYX N/A
- EPS
- CCEL N/A
- APYX N/A
- Revenue
- CCEL $31,838,476.00
- APYX $48,542,000.00
- Revenue This Year
- CCEL $3.97
- APYX N/A
- Revenue Next Year
- CCEL $0.91
- APYX $2.78
- P/E Ratio
- CCEL N/A
- APYX N/A
- Revenue Growth
- CCEL 1.95
- APYX N/A
- 52 Week Low
- CCEL $4.47
- APYX $0.97
- 52 Week High
- CCEL $9.50
- APYX $2.80
- Technical
- Relative Strength Index (RSI)
- CCEL 45.13
- APYX 54.50
- Support Level
- CCEL $7.60
- APYX $1.52
- Resistance Level
- CCEL $9.10
- APYX $1.86
- Average True Range (ATR)
- CCEL 0.27
- APYX 0.22
- MACD
- CCEL -0.15
- APYX -0.01
- Stochastic Oscillator
- CCEL 23.61
- APYX 42.06
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.